Sort
82,697 grants matching “vaccine development”
Core B: Data Management
$1,131,936Charles Goss · Washington University · U19 · FY2024 · AI
Response Therapies for MDR-TB
$1,131,873Ian M Orme · Colorado State University · U01 · FY2008 · AI
Using immune complex vaccines to optimize antibody responses to HIV Env
$1,131,742Catarina E Hioe · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
$1,131,614Kevin O Saunders · Duke University · U19 · FY2022 · AI
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,130,921Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2023 · AI
AIDS Clinical Trials Group Network
$1,130,883Constance Ann Benson · Social And Scientific Systems, Inc. · U01 · FY2009 · AI
Squirrel Monkey Breeding and Research Resource
$1,130,841William D Hopkins · University Of Tx Md Anderson Can Ctr · P40 · FY2025 · OD
Core-002
$1,130,492Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2023 · AI
Task X10: Ebola Vaccine Immunogenicity and Efficacy Testing
$1,130,027Mary Bruce · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2018 · AI
Clinical Research in the NIMH Office of the Clinical Director
$1,130,023Maryland Pao · National Institute Of Mental Health · ZIA · FY2024 · MH
Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa
$1,129,888Anavaj Sakuntabhai · Institut Pasteur · U01 · FY2024 · AI
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
$1,129,607David Eric Shapiro · Harvard School Of Public Health · U01 · FY2010 · AI
Human immune signatures of latent MTB infection, active disease and BCG vaccination
$1,129,462Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2016 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$1,129,254Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$1,129,196John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Development of MecVax, a Cross Protective Subunit Vaccine for ETEC
$1,129,161Weiping Zhang · University Of Illinois At Urbana-Champaign · R01 · FY2025 · AI
The Ohio State University AIDS Clinical Trials Unit
$1,129,143Susan L Koletar · Ohio State University · UM1 · FY2013 · AI
Philadelphia IMPAACT Clinical Trials Unit
$1,129,111Steven Daniel Douglas · Children'S Hosp Of Philadelphia · UM1 · FY2013 · AI
Dimandelic Acid Ethers As Topical Microbicides For HIV
$1,129,055Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · HD
Development of sG as a human vaccine against Nipah/Hendra
$1,129,038Timothy R Fouts · Profectus Biosciences, Inc. · R01 · FY2016 · AI
Potentiating an Anthrax DNA Vaccine with Electroporation
$1,128,919Ichor Medical Systems, Inc. · R42 · FY2004 · AI
Vaccines and Therapeutics for Anthrax
$1,128,820Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,128,779John Givens · Starks Associates Inc · N01 · FY2017 · AI
Structure-Based Vaccine Design for Hepatits C Virus
$1,128,779Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2020 · AI
Small-molecule inhibitors of flavivirus entry
$1,128,723Priscilla Li-Ning Yang · Harvard Medical School · U19 · FY2015 · AI